ARCHIVES

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

HHS Awards $85 Million For Research to Eliminate Health Disparities

November 15, 2002

In Brief: David Nathan receives Lifetime Impact Award from Boston Children’s Hospital

November 7, 2014

Clinical Trials Approved By NCI In November

December 28, 2001

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

NCI Programs: Institute Renews 10 Center Grants, Provides Complete Grant List.

January 28, 2005

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002